Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.
News Norgine gets first EU approval for WHIM syndrome therapy Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.